Condition
Child Developmental Delay
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03880383Not ApplicableCompleted
BRIGHT Coaching Program for Families
NCT03783104Not ApplicableUnknownPrimary
Maternal B12 Supplementation to Improve Infant B12 Deficiency and Neurodevelopment
NCT03010306Not ApplicableCompletedPrimary
CASITA Intervention for Children at Risk of Delay in Carabayllo, Peru
Showing all 3 trials